https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/accounts-payable-trade-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/accounts-receivable https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/accrued-employee-benefits-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/accrued-income-taxes-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/accrued-income-taxes-noncurrent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/accrued-liabilities-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/accrued-royalties-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/accumulated-depreciation https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/additional-paid-in-capital https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/advertising-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/amortization https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/amortization-of-financing-costs https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/aoci https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/basic-shares https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/business-acquisition-percentage-of-voting-interests-acquired https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/buybacks-share-repurchases https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/buybacks-shares-repurchased https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/buybacks-stock-repurchased-shares https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/buybacks-stock-repurchased-value https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/capital-expenditures https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/capital-lease-obligations-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/capitalized-contract-cost-net https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/cash-and-restricted-cash https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/cash-flow-breakdown https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/cash-provided-by-used-in-financing-activities-discontinued-operations https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/common-stock-other-shares-outstanding https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/common-stock-other-value-outstanding https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/common-stock-value https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/comprehensive-income https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/construction-in-progress-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/construction-in-progress-gross https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/contract-liability https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/contract-with-customer-asset-net https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/contract-with-customer-refund-liability-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/cost-of-revenue https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/cover-page-shares-outstanding https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/current-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/current-liabilities https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/debt-carrying-amount https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/debt-face-amount https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/debt-fair-value https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/debt-maturing-in-year-five https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/debt-maturing-in-year-four https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/debt-maturing-in-year-three https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/debt-maturing-in-year-two https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/debt-repaid https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-finance-costs-net https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-income-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-income-tax-assets-net https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-revenue-recognized https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-investment-in-subsidiaries https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-other https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-liabilities https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/deposit-liabilities-accrued-interest https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/depreciation https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/depreciation-and-amortization https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/diluted-shares https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/discontinued-operation-income-loss-from-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/discontinued-operation-tax-effect-of-discontinued-operation https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/disposal-group-including-discontinued-operation-consideration https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/effect-on-future-earnings-amount https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/effective-tax-rate https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/employee-stock-ownership-plan-esop-compensation-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/eps https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/eps-basic https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/fair-value-option-aggregate-differences-long-term-debt-instruments https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finance-lease-liability https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finance-lease-liability-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finance-lease-principal-payments https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/financing-cash-flow https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/foreign-pretax-income https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/form-d-other https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/gain-loss-on-sale-of-business https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/goodwill https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/goodwill-impairment-loss https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/gross-profit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-loss-from https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-tax https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-tax-examination-increase-decrease-in-liability-from-prior-year https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-tax-examination-interest-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-tax-examination-liability-refund-adjustment-from-settlement-with-taxing-authority https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/income-taxes-paid https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/increase-decrease-in-inventories https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/indefinitelived-intangible-assets-acquired https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/insider-transactions-stock-options https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/insider-transactions-stock-units https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/insider-transactions-warrants https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/interest-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/interest-paid-net https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/inventory https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/inventory-raw-materials-and-supplies-net-of-reserves https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/investing-cash-flow https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/lease-cost https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/liabilities-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/limited-partners-capital-account https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/line-of-credit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/litigation-settlement-amount-awarded-to-other-party https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/long-term-debt https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/long-term-debt-fair-value https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/loss-in-period https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/net-cash-from-financing-activities https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/net-cash-from-investing-activities https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/net-cash-from-operating-activities https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/net-income https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/net-income-loss-net-of-tax-per-outstanding-limited-partnership-unit-diluted https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/net-income-loss-per-outstanding-limited-partnership-unit-basic-net-of-tax https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/notes-payable-fair-value-disclosure https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/number-of-defendants https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/number-of-operating-segments https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/number-of-plaintiffs https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/number-of-reportable-segments https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/number-of-reporting-units https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/oci-financial-liability-fair-value-option-after-tax-and-reclassification-adjustment-attributable-to-parent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/oci-net-of-tax https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-cash-flow https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-expenses https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-income https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-liability https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-liability-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/other-income https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/other-income-tax-expense-benefit https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/other-long-term-debt-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/other-noncurrent-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/other-noncurrent-liabilities https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/other-nonoperating-income-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/other-receivables-net-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/paid-in-capital-income-tax-deficiency-from-share-based-compensation https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/paid-in-kind-interest https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/partners-capital https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/partners-capital-account-contributions https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/partners-capital-account-distributions https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/payment-for-contingent-consideration-liability-financing-activities https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/payment-for-contingent-consideration-liability-operating-activities https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/payments-of-capital-distribution https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/payments-of-distributions-to-affiliates https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/payments-of-loan-costs https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/pending-claims-number https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/preferred-shares-facts https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/preferred-stock-shares-issued https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/preferred-stock-value https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/pretax-income https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/pretax-income-domestic https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-divestiture-of-businesses-net-of-cash-divested https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-fees-received https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-issuance-of-secured-debt https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-partnership-contribution https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-sale-of-intangible-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/proceeds-from-stock-issued https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/profit-loss https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-after-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/property-plant-equipment https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/public-float https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/purchase-obligation https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/purchase-obligation-due-in-fourth-and-fifth-year https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/purchase-obligation-due-in-second-and-third-year https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/receivable-current https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/repayments-of-debt https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/research-and-development https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/research-and-development-in-process https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/restructuring-and-related-cost-incurred-cost https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/retained-earnings https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/revenue https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/royalty-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/sga-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/share-price https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/shareholders-equity https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/shares-authorized https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/shares-issued https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-award-purchase-price-of-common-stock-percent https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-based-compensation https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-issued-shares-issued-shares-employee-stock-ownership-plan https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/stock-repurchase-program-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-adjustments-settlements-and-unusual-provisions https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-rate-reconciliation-tax-settlements https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/total-assets https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/total-liabilities https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/total-liabilities-and-equity https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/total-long-term-debt https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/unrecognized-tax-benefits https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/valuation-allowances-and-reserves-deductions https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/weighted-average-limited-partnership-units-outstanding https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/weighted-average-limited-partnership-units-outstanding-diluted https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/rvl-pharmaceuticals-plc/write-off-of-deferred-debt-issuance-cost